Definition, analytical purpose, and adjacent boundaries
Continuous-glucose and sleep-rhythm linkage analysis models place a continuous glucose monitoring (CGM) trace, sleep-wake timing, rest-activity rhythms, and relevant context on a common timeline to describe temporal correspondence, recurring patterns, phase offsets, and within-person covariation. This entry belongs to WSIC 4.4.4, sleep digital twins and personalized prediction models. Here, however, a model may be a prespecified statistical analysis, a parametric rhythm model, or a visualization pipeline; it does not have to generate a future risk score.
This entry differs from entry 1482. That entry uses CGM information available at a prediction time to forecast a later sleep outcome or intervention response; this entry may analyze glucose and sleep rhythms that have already occurred together. It also differs from entry 1481, which concerns broader prediction involving blood-glucose fluctuation. Overlaying two traces can be exploratory, but it becomes a reproducible linkage analysis only when the sleep definition, time base, quality controls, and analytical rules are explicit.
Linkage is a descriptive term, not a synonym for synchronization, causation, or treatment effect. A glucose change after sleep onset, a correlation peak at one lag, or better daytime metrics among earlier sleepers does not by itself show that sleep produced the change. The system must state whether its question concerns a same-night within-person association, a cross-day lag, a between-person difference, a day-night pattern, or alignment around an event such as a meal or shift, and it must keep conclusions within that question.
Dual time bases, rhythm measures, and sleep phenotypes
Joint data involve at least civil clock time and time relative to an event. Civil time describes when something occurred locally; relative time describes how long before or after sleep onset, waking, a meal, or a medicine event it occurred. Travel, daylight-saving transitions, and night work additionally require UTC, the local offset, and offset changes. Splitting days at midnight breaks sleep that crosses midnight, while forcing everyone onto one clock conceals early, late, and shift-work patterns. Source timestamps, the analytical-day rule, and event anchors must therefore be retained.
Sleep rhythm may be represented by sleep onset and end, midpoint, regularity, between-day variability, social jetlag, naps, or a rest-activity phase. On the glucose side, an analysis may compare the mean, variability, shape, event exposure, and stability of sleep and wake windows or use a rhythm model to estimate mesor, amplitude, and phase. Every measure needs a formula, unit, valid-day requirement, window, and missing-data rule. A proprietary rhythm score must not be treated as a universal physiological quantity.
Behavioural sleep time, an actigraphic rest-activity rhythm, and endogenous circadian phase are not synonyms. A sleep midpoint inferred from wrist movement, a diary, or a phone primarily reflects behavioural timing. Without an appropriate physiological measure such as dim-light melatonin onset or core body temperature, the product should not claim that it measured biological-clock phase. Polysomnography, research actigraphy, consumer wearables, and bedside sensors also have different errors, and a proprietary deep-sleep label is not automatically an electroencephalographic sleep stage.
Acquisition chain, sleep windows, and data quality
CGM generally measures glucose in subcutaneous interstitial fluid and is affected by physiological lag, algorithmic smoothing, calibration, wear day, rapid change, perfusion, interferents, and device version. Pressure on a sensor during sleep can produce a sudden fall and unusual recovery, while loosening, wireless interruption, an offline phone, or depleted battery can create gaps. Analysis should retain source values and quality flags and distinguish suspected compression, short and long missing intervals, interpolation, and genuine extremes instead of smoothing or deleting them all alike.
A sleep window should come from a documented method rather than a default midnight-to-morning interval. A fixed clock interval misses early, delayed, shift, split, and nap sleep and may count awake eating, alarm response, or medicine administration as sleep. Clocks in a sleep device, CGM, pump, phone, and diary may drift or duplicate timestamps. The pipeline should check sampling rate, unit, time zone, daylight-saving changes, midnight crossing, scan gaps, identity mismatch, and device replacement, and retain an auditable record of corrections.
Alerts and responses are part of the data-generating process. A CGM alert may cause awakening, confirmatory measurement, eating, medicine administration, caregiver action, or automated delivery, simultaneously changing sleep and the later trace. Analysis should distinguish the physiological signal before the alert, the alert itself, a manual or automated response, and readings after that response. Otherwise, device-mediated waking may be mislabelled as a direct glucose effect, or a treatment-mediated improvement in the trace may be attributed to a sleep stage.
Linkage methods, lag estimation, and statistical constraints
Common methods include summaries within an actual sleep window, event-aligned curves with sleep onset or waking as time zero, stratified trajectories, cross-correlation or distributed-lag analysis, and rhythm regression that estimates mesor, amplitude, and phase. The prespecified question should determine the method. A maximum cross-correlation peak, similar shape after dynamic alignment, or coloured region in a heat map shows correspondence under a particular preprocessing pipeline. Filtering, smoothing, window length, and autocorrelation can all move or magnify the apparent best lag.
Minute-level CGM values and consecutive nights from one person are not independent observations. Inference should address repeated measurements within a person, within-night autocorrelation, season, and day-of-week structure using mixed effects, generalized estimating equations, time-series methods, or another design-appropriate approach. Within-person and between-person effects must be separated: a difference between habitual early and late sleepers does not substitute for the change seen when one person sleeps earlier than usual. Searching many measures, windows, lags, and subgroups requires multiplicity control and complete reporting of exploratory findings.
Missingness is often informative. Discomfort, severe events, shift work, device alerts, or sensor failure may produce both missing observations and rhythm changes. The analysis should report valid participants, valid nights, fully synchronized duration, exclusion reasons, imputation, and each person's contribution, with sensitivity analyses across sleep definitions, compression detection, windows, and lag ranges. Every phase offset should carry uncertainty and coverage information; it must not be marketed as a precise personal metabolic clock.
Physiological interpretation, confounding, and causal limits
Controlled experiments indicate that endogenous circadian phase, the behavioural cycle, and circadian misalignment can separately influence glucose tolerance, insulin sensitivity, or insulin secretion. Concurrent observational studies also find covariation between sleep timing, duration, or regularity and some CGM measures. This evidence supports study of temporal structure, but it does not mean that every phase relation observed by a consumer device has the same mechanism, nor may a population-average effect be treated directly as an individual treatment target.
Meal timing and composition, insulin and other medicines, automated delivery, exercise, alcohol, caffeine, stress, pain, infection, menstruation or pregnancy, sleep apnea, and shift work may affect both time series. Prior sleep also changes next-day appetite, activity, and treatment execution, while glucose symptoms and alerts can disrupt sleep in the opposite direction. Same-night, next-day, and previous-day variables therefore need an explicit temporal order, and variables occurring after treatment should not be adjusted as though they were ordinary baseline confounders.
A claim that changing sleep timing will improve glucose, or that changing glucose will restore a sleep rhythm, requires a defined intervention and comparator, a causal diagram, exchangeability and timing assumptions, and preferably randomized or another defensible causal design. Correlation, Granger-style precedence, feature importance, clustering, and an individual's before-after plot cannot independently establish causation. Findings from simulated night work, fixed meal schedules, or forced desynchrony in a laboratory must also be interpreted under those experimental conditions and not generalized to every home routine without validation.
Validation, presentation, and practical use
Before inspecting outcome patterns, an analysis plan should define the population, minimum valid days, sleep and glucose measures, alignment anchor, primary lags, covariates, exclusions, and uncertainty method. Reproduction requires frozen code and versioned inputs, followed by evaluation across CGM systems, sleep measures, diabetes types, treatments, seasons, ages, and schedules. An individual's previous pattern may no longer apply after sensor or algorithm replacement, travel, treatment change, or a long-term health change.
Useful outputs include dual-track timelines with quality masking, average curves aligned to sleep events, distributions of phase across days, and within-person effects with confidence intervals. The interface should show data dates, valid nights, sleep reference, device and algorithm versions, interpolation, and suspected artefact rather than only a red-green score. A population mean must not hide the individual distribution, and statistical significance does not show that a difference is large enough to change health or workflow.
Linkage analysis can organize a diary, identify temporal patterns that deserve review, inform research design, or support discussion with a professional. By itself it cannot diagnose insomnia, a circadian rhythm disorder, sleep apnea, hypoglycaemia, or hyperglycaemia. A phase chart must not be used alone to increase or reduce insulin or another medicine, change pump settings, eat extra carbohydrate, or stop existing treatment. When readings conflict with symptoms, device-specific instructions and the individualized professional plan apply; emergencies require the established emergency pathway.
Privacy, regulation, and lifecycle governance
Combining CGM, sleep, meal, medicine, activity, location, and bedroom-sensor data can expose illness, work shifts, household activity, and information about a bed partner. Collection should be minimized to the purpose, permissions should distinguish the individual, caregiver, clinician, researcher, and supplier, and policy should define live sharing, secondary training, retention, export, correction, deletion, and revocation. De-identification, aggregation, or edge processing does not automatically eliminate re-identification from dense temporal patterns.
Whether a product is a research tool, general wellness visualization, clinical decision support, or a medical device depends on intended use and local rules. Outputs used for disease screening, alerts, treatment selection, or automated control require risk-proportionate software quality, clinical evidence, human-factors work, cybersecurity, and a regulatory pathway. An authorized CGM or sleep device supplying data does not automatically confer the same authorization on a third-party linkage algorithm, cloud update, or recommendation.
Lifecycle records should connect source data, clock correction, devices and firmware, sleep definitions, cleaning rules, analytical code, the prespecified plan, validation, interface, permissions, and changes. Monitoring should cover missingness, mismatch, suspected compression, phase and effect distributions, subgroup differences, human corrections, and harm signals. Any update to device support, sampling, alignment, filtering, windows, lag searches, rhythm formulas, or explanatory text needs cumulative-impact assessment, revalidation, and a clear statement about whether old and new results remain comparable.